Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Strata Critical Medical, Inc.NASDAQ: SRTA

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income turns positive

Q1 FY2026 net income was $2.4M, compared with -$3.49M a year earlier. Trailing-twelve-month net income was -$19.83M.

Context

  • Net income amounted to 21.0% of revenue in FY2025, up 10.0 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of -$5.76M (-113.9%) for the fiscal year ending Dec 2026, a slowdown from the +251.4% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.4M+127.2% QoQ
Last fiscal yearDec 2025
$41.35M+251.4% YoY
LTMMar 2026
-$19.83M-25.4% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+168.8%-52.8%-221.6 pp
1 year+251.4%-113.9%-365.4 pp
3-year CAGR—-33.1%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
41.35M USD
Year-over-year change
+251.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -25.4% is the 5th highest of 9, against a peer median of -19.5%.
  • Net income amounts to 7.8% of revenue for SRTA, versus a peer median of 8.8%.
SRTA Competitors
Net Income for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EVTLVertical Aerospace Ltd.LTM Mar 2026£237.85M GBP———
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$152.56M USD-282.8%—9.9%
EBFEnnis, Inc.LTM Feb 2026$42.63M USD+6.0%-3.4%10.9%
CYRXCryoport, Inc.LTM Mar 2026$36.31M USD-66.3%—19.8%
KFRCKforce Inc.LTM Mar 2026$34.61M USD-27.3%-22.7%2.6%
FLYXflyExclusive, Inc.LTM Mar 2026$33.82M USD-11.7%+152.8%8.8%
ZIPZipRecruiter, Inc.LTM Mar 2026$24.9M USD+29.8%—5.6%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$19.83M USD-25.4%—7.8%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$17.58M USD—-45.6%20.0%
MTRXMatrix Service CompanyLTM Mar 2026$14.99M USD-33.6%-22.7%1.8%
ORNOrion Group Holdings, Inc.LTM Mar 2026$9.43M USD+214.4%—1.1%
Peer median (excluding SRTA) —-19.5%-22.7%8.8%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.